These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 6896207

  • 21. Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease.
    Amino N, Tada H, Hidaka Y.
    Thyroid; 1999 Jul; 9(7):705-13. PubMed ID: 10447018
    [Abstract] [Full Text] [Related]

  • 22. Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease.
    Amino N, Yabu Y, Miyai K, Fujie T, Azukizawa M, Onishi T, Kumahara Y.
    Lancet; 1978 Aug 12; 2(8085):344-6. PubMed ID: 79711
    [Abstract] [Full Text] [Related]

  • 23. Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves' disease.
    Hashizume K, Ichikawa K, Nishii Y, Kobayashi M, Sakurai A, Miyamoto T, Suzuki S, Takeda T.
    J Clin Endocrinol Metab; 1992 Jul 12; 75(1):6-10. PubMed ID: 1642700
    [Abstract] [Full Text] [Related]

  • 24. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
    Uenaka M, Tanimura K, Tairaku S, Morioka I, Ebina Y, Yamada H.
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun 12; 177():89-93. PubMed ID: 24726178
    [Abstract] [Full Text] [Related]

  • 25. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M, Koizumi Y, Aizawa T, Yamada T, Takahashi Y, Watanabe T, Kamoi K.
    J Clin Endocrinol Metab; 1988 Jan 12; 66(1):103-8. PubMed ID: 3121661
    [Abstract] [Full Text] [Related]

  • 26. Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels.
    Shigemasa C, Abe K, Taniguchi S, Mitani Y, Ueda Y, Adachi T, Urabe K, Tanaka T, Yoshida A, Mashiba H.
    J Clin Endocrinol Metab; 1987 Aug 12; 65(2):359-63. PubMed ID: 3110204
    [Abstract] [Full Text] [Related]

  • 27. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
    Ota H, Amino N, Morita S, Kobayashi K, Kubota S, Fukata S, Kamiyama N, Miyauchi A.
    Clin Endocrinol (Oxf); 2007 Jul 12; 67(1):41-5. PubMed ID: 17437515
    [Abstract] [Full Text] [Related]

  • 28. Transient Graves' hyperthyroidism during pregnancy in a patient with Hashimoto's hypothyroidism.
    Lu R, Burman KD, Jonklaas J.
    Thyroid; 2005 Jul 12; 15(7):725-9. PubMed ID: 16053390
    [Abstract] [Full Text] [Related]

  • 29. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?
    Yoshihara A, Noh JY, Mukasa K, Suzuki M, Ohye H, Matsumoto M, Kunii Y, Watanabe N, Suzuki N, Kameda T, Sugino K, Ito K.
    Endocr J; 2015 Jul 12; 62(6):557-60. PubMed ID: 25819223
    [Abstract] [Full Text] [Related]

  • 30. [Analysis of circulating thyroid-stimulating activities in pregnant women with Graves' disease: differential measurement of activities induced by TSH receptor antibody and hCG].
    Kaneda T, Tamaki H, Hidaka Y, Amino N, Mitsuda N, Tanizawa O, Miyai K.
    Rinsho Byori; 1992 Sep 12; 40(9):941-7. PubMed ID: 1434029
    [Abstract] [Full Text] [Related]

  • 31. Gestational and Postpartum Complications in Patients with First Trimester Thyrotoxicosis: A Prospective Multicenter Cohort Study from Northeast China.
    Xu Y, Li C, Wang W, Yu X, Liu A, Shi Y, Xie X, Li J, Li Y, Shan Z, Teng W, Li Y.
    Thyroid; 2023 Jun 12; 33(6):762-770. PubMed ID: 37051708
    [Abstract] [Full Text] [Related]

  • 32. Prolonged suppressed thyroid-stimulating hormone levels in hyperthyroidism in a neonate born to a mother with Graves' disease.
    Hojo M, Momotani N, Ikeda N, Ueda A, Uno K, Ishikita T, Ishiguro A, Shimbo T.
    Acta Paediatr Jpn; 1998 Oct 12; 40(5):483-5. PubMed ID: 9821712
    [Abstract] [Full Text] [Related]

  • 33. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.
    Okamoto Y, Hamada N, Saito H, Ohno M, Noh J, Ito K, Morii H.
    J Clin Endocrinol Metab; 1989 Apr 12; 68(4):730-4. PubMed ID: 2921308
    [Abstract] [Full Text] [Related]

  • 34. A long-term follow-up study of patients with non-toxic diffuse goitre in Japan.
    Hara T, Tamai H, Mukuta T, Fukata S, Kuma K, Nakagawa T.
    Clin Endocrinol (Oxf); 1993 Nov 12; 39(5):541-6. PubMed ID: 8252742
    [Abstract] [Full Text] [Related]

  • 35. [Laboratory diagnosis before onset and prediction of Graves' disease].
    Hidaka Y, Tada H, Amino N.
    Rinsho Byori; 1997 Sep 12; 45(9):825-30. PubMed ID: 9311254
    [Abstract] [Full Text] [Related]

  • 36. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y.
    J Clin Endocrinol Metab; 2000 Nov 12; 85(11):4157-61. PubMed ID: 11095447
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC, Ingbar SH.
    J Clin Invest; 1979 Nov 12; 64(5):1429-36. PubMed ID: 91625
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK, Larsen PR.
    J Clin Endocrinol Metab; 2002 Mar 12; 87(3):1073-7. PubMed ID: 11889166
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.